Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2022 · 10-Q
Revenue$2.41B$2.41B+3.5% vs Q1 2021 Net Income$39.28M$39.28M−43.6% vs Q1 2021 EPS Diluted$0.52$0.52−46.9% vs Q1 2021 Gross Profit$373,448,000−15.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow$79,699,000+213.5% Free Cash Flowderived$70,090,000+244.0% Margins · derivedGross margin15.5%−3.5 pt vs Q1 2021
Operating margin2.5%−3.8 pt vs Q1 2021
Net margin1.6%−1.4 pt vs Q1 2021
ended Mar 31, 2022 · filed May 4, 2022 · 34 d after period end